Related Experiment Video
Updated: May 24, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Prevalence of Germline Pathogenic RET Variants in a Pan-Cancer Patient Population
Matilde Borio1, Margaret Sheehan1, Nora Katabi2
1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Germline RET variants (LP/PV) are linked to medullary thyroid cancer (MTC). Many patients with RET LP/PVs lack MTC history, highlighting the need for surveillance and potential thyroidectomy.
Area of Science:
- Oncology
- Genetics
- Endocrinology
Background:
- Germline likely pathogenic or pathogenic variants (LP/PV) in the RET proto-oncogene are implicated in approximately 25% of medullary thyroid cancers (MTCs).
- Individuals with RET LP/PVs face a significant lifetime risk of MTC or C-cell hyperplasia, a precursor lesion.
Purpose of the Study:
- To assess the prevalence and genotype-phenotype correlations of RET LP/PVs in a diverse, pan-cancer population undergoing agnostic multigene germline cancer genetic testing.
- To identify incidental findings of RET LP/PVs in patients without a personal or family history of MTC.
Main Methods:
- Utilized data from Memorial Sloan Kettering Cancer Center patients undergoing paired tumor-normal genomic sequencing (ClinicalTrials.gov identifier: NCT01775072) from 2015 to 2023.
- Included multigene germline testing for RET variants and categorized LP/PVs according to standardized MTC risk levels.
- Extracted clinical data, including family history, surveillance results, and pathology, from electronic medical records.
Main Results:
- Identified 21 patients with RET LP/PVs out of 31,866 patients; the most common variant was p.Val804Met (n=10).
- 71% of patients (15/21) with RET LP/PVs had no personal or family history of MTC.
- Among those without a history, nine underwent high-risk surveillance, leading to thyroidectomy in five due to precursor lesions or MTC.
Conclusions:
- A significant proportion of germline RET LP/PV findings in a pan-cancer cohort are incidental, lacking a prior MTC history.
- High-risk surveillance and consideration for thyroidectomy are crucial for patients with incidental germline RET LP/PV findings due to the risk of MTC and precursor lesions.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Non-LTR Retrotransposons
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
